Inogen | INGN - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Abbott USD 11.66B 1.2B 2026-09
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 150.1M 6.16M 2026-09
Baxter International USD 6.5B 3.82B 2026-09
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 4.13B 72M 2026-09
Cooper Companies USD 844.2M 268.3M 2026-06
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 10.86B 9.64B 2026-09
Globus Medical USD 835.58M 239.73M 2026-06
Inogen USD 49.14M 665K 2024-09
Insulet USD 652.2M 19.8M 2026-09
Medtronic USD 7.92B 203M 2026-06
Orthofix International USD 213.79M 12.36M 2025-12
Philips EUR 3.75B 147M 2026-06
ResMed USD 1.01B 83.57M 2026-06
Steris USD 1.27B 62.5M 2026-09
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Teleflex USD 3.49B 589.18M 2026-09
X T L Biopharmaceuticals USD 1.1M 175K 2024-12
Zimmer Biomet Holdings USD 1.72B 110.9M 2026-09